Clinical Trial Update: Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of adding interleukin-2 to pegylated interferon alfa-2a and ribavirin in patients coinfected with HIV and hepati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections, Chronic Hepatitis C | Phase 2 | Status: COMPLETED